Trial intelligence / Profile preview

Val-CARD: Pre-surgery Sodium Valproate to Prevent Organ Injury in Cardiac Surgery

2018-002076-41Phase 2Unknown

Sponsor
University of Leicester
Start
Jul 2018
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised trial of divalproex sodium in acute kidney failure (AKF), cardiac morbidity, Myocardial injury and 1 more (2 arms), sponsored by University of Leicester. Primary endpoints: Serial biomarkers of renal injury and Serial biomarkers of myocardial injury. Status: unknown.

02

Drugs

divalproex sodium
03

Conditions

acute kidney failure (AKF)cardiac morbidityMyocardial injurymultiple organ dysfunction syndrome (MODS)

Beyond the preview

Go deeper on 2018-002076-41.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2018-002076-41.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call